{
    "clinical_study": {
        "@rank": "77106", 
        "arm_group": [
            {
                "arm_group_label": "obese patients", 
                "description": "BMI (body mass index) more than or equal to 35 kg/m2 (weight in kilograms divided by the square of the height in metres)"
            }, 
            {
                "arm_group_label": "Thin patients", 
                "description": "BMI less than or equal to 30 kg/m2"
            }
        ], 
        "brief_summary": {
            "textblock": "This study is to determine if there is a rise in eye pressure, when patients are placed in a\n      position where the head is lower than the rest of the body during long surgeries."
        }, 
        "brief_title": "A Comparison of Intraocular Pressures (IOP) During Prolonged Trendelenburg Positioning in Morbidly Obese and Thin Patients", 
        "completion_date": {
            "#text": "January 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Intraocular Pressure Disorder", 
        "detailed_description": {
            "textblock": "Eye pressure will be measured at protocol specified intervals."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Subjects undergoing prolonged procedures (scheduled >3hr) in steep  Trendelenburg\n             position (eg. robotic prostatectomy, hysterectomy, cystectomy)\n\n          2. Morbidly obese subjects:  BMI \u2265 35 kg/m2\n\n          3. Thin subjects:  BMI \u2264 30 kg/m2\n\n          4. Age 18-70\n\n          5. ASA (American Society of Anesthesiologists) physical status classification I, II, or\n             III\n\n        Exclusion Criteria:\n\n          1. Known history of glaucoma\n\n          2. Note:if initial IOP is noted to be >21mmHg (millimeters of mercury), patient will be\n             excluded from study and an ophthalmology consultation will be obtained.Surgery will\n             not be postponed.\n\n          3. Recent use of IOP lowering topical ophthalmic agents\n\n          4. Allergy to latex or proparacaine hydrochloride ophthalmic solution\n\n          5. Patients with active corneal epithelial defects or history of recurrent corneal\n             erosion\n\n          6. Patients with underlying disorders that can directly increase intraocular pressure\n             (thyroid eye disease, intra orbital tumors, orbital vascular malformation,\n             Sturge-Weber disease, carotid or dural cavernous arteriovenous malformation,\n             cavernous sinus pathology)\n\n          7. History of corneal surgery, to include LASIK (laser-assisted in-situ keratomileusis)\n\n          8. Any eye surgery within prior 1 month\n\n          9. Known pregnancy\n\n         10. Cognitive impairment"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "70 Years", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Adult Subjects undergoing prolonged  procedures expected to be in steep Trendelenburg\n        position. Procedure must be scheduled for  > 3 hours, eg. robotic prostatectomy,\n        hysterectomy, and cystectomy."
            }
        }, 
        "enrollment": {
            "#text": "40", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 16, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01737645", 
            "org_study_id": "2011-273"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "October 25, 2013", 
        "location": {
            "contact": {
                "email": "Cynthia.Turzewksi@beaumont.edu", 
                "last_name": "Cynthia Turzewski,RN, BSN", 
                "phone": "248-898-1907"
            }, 
            "facility": {
                "address": {
                    "city": "Royal Oak", 
                    "country": "United States", 
                    "state": "Michigan", 
                    "zip": "48073"
                }, 
                "name": "William Beaumont Hospital"
            }, 
            "investigator": {
                "last_name": "Roy Soto, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "2", 
        "official_title": "A Comparison of Intraocular Pressures (IOP) During Prolonged Trendelenburg Positioning in Morbidly Obese and Thin Patients", 
        "overall_contact": {
            "email": "Cynthia.turzewski@beaumont.edu", 
            "last_name": "Cynthia Turzewski, RN, BSN", 
            "phone": "248-898-1907"
        }, 
        "overall_official": {
            "affiliation": "William Beaumont Hospitals", 
            "last_name": "Roy G Soto, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "To compare the percent change from baseline IOP reading to the peak IOP reading during steep Trendelenburg positioning in thin subjects vs morbidly obese subjects.", 
            "safety_issue": "No", 
            "time_frame": "Measured from baseline IOP to peak IOP during steep Trendelenburg.  The overall time frame for which the outcome measure is assessed is up to 3 years."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01737645"
        }, 
        "responsible_party": {
            "investigator_affiliation": "William Beaumont Hospitals", 
            "investigator_full_name": "Roy Soto, MD", 
            "investigator_title": "Principal Investigator", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "To determine rate of rise of IOP during steep Trendelenburg positioning", 
                "safety_issue": "No", 
                "time_frame": "The time during the surgery when the patient is in steep Trendelenburg positioning. The overall time frame for which the outcome measure is assessed is up to 3 years."
            }, 
            {
                "measure": "To compare peak IOP and rise of IOP during steep Trendelenburg positioning in thin vs morbidly obese subjects.", 
                "safety_issue": "No", 
                "time_frame": "The time during the surgery when the patient is in steep Trendelenburg positioning.  The overall time frame for which the outcome measure is assessed is up to 3 years."
            }
        ], 
        "source": "William Beaumont Hospitals", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "William Beaumont Hospitals", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 2012", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "October 2013"
    }
}